Transcatheter Closure of Perimembranous Ventricular Septal Defects Using Different Generations of Amplatzer Devices: Multicenter Experience
Autor: | Tatiana Molina-Sánchez, Rodina Sobhy, Roberto Mijangos-Vázquez, Amal El-Sisi, Juan P Sandoval Jones, Mohammed Soliman, Carlos Zabal, José Antonio García-Montes, Antoine Fakhry AbdelMassih, Safaa M. Ali, Rogelio Hernández-Reyes |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Heart Septal Defects
Ventricular Male medicine.medical_specialty Cardiac Catheterization Article Subject Heart block Septal Occluder Device Closure (topology) 030204 cardiovascular system & hematology Closure rate Prosthesis Implantation 03 medical and health sciences 0302 clinical medicine Medicine Diseases of the circulatory (Cardiovascular) system Humans Radiology Nuclear Medicine and imaging 030212 general & internal medicine Mexico Retrospective Studies Mitral regurgitation Heart septal defect Equipment Safety business.industry Retrospective cohort study medicine.disease Surgery Heart Block Treatment Outcome RC666-701 Child Preschool Safety Equipment Female Risk Adjustment Cardiology and Cardiovascular Medicine business Research Article |
Zdroj: | Journal of Interventional Cardiology Journal of Interventional Cardiology, Vol 2020 (2020) |
ISSN: | 1540-8183 0896-4327 |
Popis: | Objectives. To demonstrate safety and efficacy of using different generations of softer Amplatzer™ devices for ventricular septal defect (VSD) closure to avoid serious complications at follow-up. Background. Transcatheter closure of perimembranous ventricular septal defects (PmVSD) is a well-established procedure; however, it is associated with unacceptable incidence of complete heart block. Great advantages have been achieved by using softer devices for VSD transcatheter closure. The first and second generation of Amplatzer™ occluders (AVP II, ADO, and ADO II) seem to offer a safe and attractive alternative for this procedure. These devices can be delivered using either an arterial (retrograde) or venous (prograde) approach. Methods and Results. Patients with congenital PmVSD who underwent transcatheter closure using ADO, ADO II, and AVP II devices were included. Primary end point was to determine efficacy and safety of these generations of devices and to determine the incidence of complications at follow-up (complete AV block and aortic/tricuspid/mitral regurgitation). One hundred and nineteen patients underwent VSD closure at a median age of 5 years (8 months–54 years). During the catheterization, there were only minor complications and at follow-up of 36 ± 25.7 months (up to 99 months), the closure rate was high of 98.3% and freedom from AV block was 100%. Conclusions. The use of softer Amplatzer™ devices is a good alternative to achieve PmVSD closure safely with no risk of AVB during the procedure or at midterm follow-up. |
Databáze: | OpenAIRE |
Externí odkaz: |